A new study published in Engineering has identified enolase 2 (ENO2) as a key factor in the lymphatic metastasis of head and neck squamous cell ...

The Company reported a net loss of approximately $17.0 million, or a net loss per basic and diluted share of $1.39, for the ...

The addition of chemotherapy to radiotherapy was not associated with improved survival among patients with intermediate-risk ...